| Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria FHA Osier, G Fegan, SD Polley, L Murungi, F Verra, KKA Tetteh, B Lowe, ... Infection and immunity 76 (5), 2240-2248, 2008 | 456 | 2008 |
| A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses DJ Conway, DR Cavanagh, K Tanabe, C Roper, ZS Mikes, N Sakihama, ... Nature medicine 6 (6), 689-692, 2000 | 321 | 2000 |
| A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan DR Cavanagh, IM Elhassan, C Roper, VJ Robinson, H Giha, AA Holder, ... The Journal of Immunology 161 (1), 347-359, 1998 | 241 | 1998 |
| Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria WG Metzger, DMN Okenu, DR Cavanagh, JV Robinson, KA Bojang, ... Parasite immunology 25 (6), 307-312, 2003 | 170 | 2003 |
| High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya SD Polley, DJ Conway, DR Cavanagh, JS McBride, BS Lowe, ... Vaccine 24 (19), 4233-4246, 2006 | 162 | 2006 |
| Antibodies to the N-Terminal Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Associated with Protection against Clinical Malaria DR Cavanagh, D Dodoo, L Hviid, JAL Kurtzhals, TG Theander, ... Infection and immunity 72 (11), 6492-6502, 2004 | 134 | 2004 |
| Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas C Challen, K Guo, JD Collier, D Cavanagh, MF Bassendine Journal of hepatology 14 (2-3), 342-346, 1992 | 93 | 1992 |
| α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized … L Stevenson, E Laursen, GJ Cowan, B Bandoh, L Barfod, DR Cavanagh, ... PLoS pathogens 11 (7), e1005022, 2015 | 90 | 2015 |
| Repeat Sequences in Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Targets of Antibodies Associated with Protection from Malaria SD Polley, KKA Tetteh, DR Cavanagh, RJ Pearce, JM Lloyd, KA Bojang, ... Infection and immunity 71 (4), 1833-1842, 2003 | 90 | 2003 |
| Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum DR Cavanagh, C Dobaño, IM Elhassan, K Marsh, A Elhassan, L Hviid, ... Infection and immunity 69 (2), 1207-1211, 2001 | 89 | 2001 |
| Novel organization of the site‐specific integration and excision recombination functions of the Staphylococcus aureus serotype F virulence‐converting phages φ13 … D Carroll, MA Kehoe, D Cavanagh, DC Coleman Molecular microbiology 16 (5), 877-893, 1995 | 83 | 1995 |
| Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1 DR Cavanagh, JS McBride Molecular and biochemical parasitology 85 (2), 197-211, 1997 | 77 | 1997 |
| Plasmodium falciparum 19-Kilodalton Merozoite Surface Protein 1 (MSP1)-Specific Antibodies That Interfere with Parasite Growth In Vitro Can Inhibit MSP1 … DK Moss, EJ Remarque, BW Faber, DR Cavanagh, DE Arnot, ... Infection and immunity 80 (3), 1280-1287, 2012 | 69 | 2012 |
| Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte … JPA Lusingu, ATR Jensen, LS Vestergaard, DT Minja, MB Dalgaard, ... Infection and immunity 74 (5), 2867-2875, 2006 | 59 | 2006 |
| A Longitudinal Study of Human Antibody Responses toPlasmodium falciparum Rhoptry-Associated Protein 1 in a Region of Seasonal and Unstable Malaria … PN Fonjungo, IM Elhassan, DR Cavanagh, TG Theander, L Hviid, ... Infection and immunity 67 (6), 2975-2985, 1999 | 50 | 1999 |
| Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria N Imai, N Rujeni, N Nausch, CD Bourke, LJ Appleby, G Cowan, R Gwisai, ... Parasitology 138 (12), 1519-1533, 2011 | 47 | 2011 |
| Diversity Covering AMA1-MSP119 Fusion Proteins as Malaria Vaccines BW Faber, S Younis, EJ Remarque, R Rodriguez Garcia, V Riasat, ... Infection and immunity 81 (5), 1479-1490, 2013 | 45 | 2013 |
| Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202. 11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas B Adu, MK Cherif, S Bosomprah, A Diarra, FKN Arthur, EK Dickson, ... Malaria journal 15, 1-12, 2016 | 44 | 2016 |
| Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-Stage Plasmodium falciparum DE Arnot, DR Cavanagh, EJ Remarque, AM Creasey, MPK Sowa, ... Clinical and Vaccine Immunology 15 (9), 1345-1355, 2008 | 44 | 2008 |
| Antibody Responses to Plasmodium falciparum Merozoite Surface Protein–1 and Efficacy of Amodiaquine in Gabonese Children with P. falciparum Malaria DP Mawili-Mboumba, S Borrmann, DR Cavanagh, JS McBride, ... The Journal of infectious diseases 187 (7), 1137-1141, 2003 | 41 | 2003 |
